Strumento inattivo

Altre lingue IMARA

Azioni

IMRA

US45249V1070

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Enliven Therapeutics Completes Merger With Imara	24/02/23
IMARA Inc.(NasdaqGS:IMRA) dropped from NASDAQ Composite Index	23/02/23
Enliven Therapeutics, Inc. completed the acquisition of IMARA Inc. from a group of shareholders for approximately $340 million in a reverse merger transaction.	23/02/23
IMARA INC. : Material Modification to Rights of Security Holders, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	22/02/23
Imara Announces Stockholder Approval of Merger With Enliven	22/02/23
Imara Announces Stockholder Approval of Merger With Enliven	22/02/23
IMARA INC. : Other Events (form 8-K)	13/02/23
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	10/02/23
IMARA Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	10/02/23
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	25/01/23
Top Premarket Decliners	09/01/23
IMARA INC. : Other Events (form 8-K)	05/12/22
IMARA INC. Financial Statements and Exhibits (form 8-K/A)	16/11/22
IMARA INC. : Completion of Acquisition or Disposition of Assets, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	10/11/22
Cardurion Pharmaceuticals, LLC acquired Tovinontrine (IMR-687) and All of the Assets Related to PDE9 Program from IMARA Inc. for approximately $95.	10/11/22
IMARA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	25/10/22
IMARA Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/10/22
IMARA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Imara Inc. - IMRA	15/10/22
Sector Update: Health Care Stocks Ending with Modest Declines	14/10/22
Sector Update: Health Care Stocks Sliding with Broader Friday Markets	14/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue IMARA

Azioni

IMRA

US45249V1070

Altre lingue

Filtri